These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21075627)

  • 1. Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD.
    Jones LH; Baldock H; Bunnage ME; Burrows J; Clarke N; Coghlan M; Entwistle D; Fairman D; Feeder N; Fulton C; Hilton L; James K; Jones RM; Kenyon AS; Marshall S; Newman SD; Osborne R; Patel S; Selby MD; Stuart EF; Trevethick MA; Wright KN; Price DA
    Bioorg Med Chem Lett; 2011 May; 21(9):2759-63. PubMed ID: 21075627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivalent dual pharmacology muscarinic antagonist and β₂ agonist (MABA) molecules for the treatment of COPD.
    Hughes AD; McNamara A; Steinfeld T
    Prog Med Chem; 2012; 51():71-95. PubMed ID: 22520472
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment on: Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity?
    Porru D
    Eur Urol; 2009 Mar; 55(3):720. PubMed ID: 18584943
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment on: Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity?
    Rembratt A
    Eur Urol; 2009 Mar; 55(3):719. PubMed ID: 18584945
    [No Abstract]   [Full Text] [Related]  

  • 5. Triple inhalers for obstructive airways disease: will they be useful?
    Barnes PJ
    Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649
    [No Abstract]   [Full Text] [Related]  

  • 6. Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β
    Rancati F; Linney ID; Rizzi A; Delcanale M; Knight CK; Schmidt W; Pastore F; Riccardi B; Mileo V; Carnini C; Cesari N; Blackaby WP; Patacchini R; Carzaniga L
    Bioorg Med Chem Lett; 2021 Jun; 41():127975. PubMed ID: 33753262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient conversion of a nonselective norepinephrin reuptake inhibitor into a dual muscarinic antagonist-β₂-agonist for the treatment of chronic obstructive pulmonary disease.
    Osborne R; Clarke N; Glossop P; Kenyon A; Liu H; Patel S; Summerhill S; Jones LH
    J Med Chem; 2011 Oct; 54(19):6998-7002. PubMed ID: 21863888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of bladder weakness].
    Wagenlehner FM
    Dtsch Med Wochenschr; 2005 Jan; 130(3):118. PubMed ID: 15650964
    [No Abstract]   [Full Text] [Related]  

  • 9. Dual β2-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD.
    Shan WJ; Huang L; Zhou Q; Jiang HL; Luo ZH; Lai KF; Li XS
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1523-6. PubMed ID: 22297114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.
    Mete A; Bowers K; Bull RJ; Coope H; Donald DK; Escott KJ; Ford R; Grime K; Mather A; Ray NC; Russell V
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6248-53. PubMed ID: 24144851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia.
    Siegler EL; Reidenberg M
    Clin Pharmacol Ther; 2004 May; 75(5):484-8. PubMed ID: 15116061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New dual-acting bronchodilator treatments for COPD, muscarinic antagonists and β2 agonists in combination or combined into a single molecule.
    Norman P
    Expert Opin Investig Drugs; 2013 Dec; 22(12):1569-80. PubMed ID: 23962341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment on: Urinary incontinence at orgasm: relation to detrusor overactivity and treatment efficacy.
    Kuo HC
    Eur Urol; 2008 Oct; 54(4):915-6. PubMed ID: 18036725
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment on: Urinary incontinence at orgasm: relation to detrusor overactivity and treatment efficacy.
    Roumeguère T
    Eur Urol; 2008 Oct; 54(4):916-7. PubMed ID: 18036722
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination therapy with desmopressin and an anticholinergic medication for nonresponders to desmopressin for monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial.
    Austin PF; Ferguson G; Yan Y; Campigotto MJ; Royer ME; Coplen DE
    Pediatrics; 2008 Nov; 122(5):1027-32. PubMed ID: 18977983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic antagonist-beta-adrenergic agonist dual pharmacology molecules as bronchodilators: a patent review.
    Ray NC; Alcaraz L
    Expert Opin Ther Pat; 2009 Jan; 19(1):1-12. PubMed ID: 19441894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycopyrronium + indacaterol. A fixed-dose combination with no advantages in COPD.
    Prescrire Int; 2014 Dec; 23(155):288. PubMed ID: 25629143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled muscarinic antagonists for respiratory diseases: a review of patents and current developments (2006 - 2010).
    Prat M; Gavaldà A; Fonquerna S; Miralpeix M
    Expert Opin Ther Pat; 2011 Oct; 21(10):1543-73. PubMed ID: 21702714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysis.
    Penning-van Beest F; van Herk-Sukel M; Gale R; Lammers JW; Herings R
    Respir Med; 2011 Feb; 105(2):259-65. PubMed ID: 20705441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M(2)-β(2) interaction: a basis for combined bronchodilator treatment.
    López-Campos JL
    Arch Bronconeumol; 2013 Jul; 49(7):279-81. PubMed ID: 23122560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.